Literature DB >> 11504672

Estrogens and cell-cycle regulation in breast cancer.

J S Foster1, D C Henley, S Ahamed, J Wimalasena.   

Abstract

Clinical and experimental data have established that the leading cause of sporadic female breast cancer is exposure to estrogens, predominantly 17beta-estradiol. Recent advances in the understanding of cell-cycle control mechanisms have been applied to outline the molecular mechanisms through which estrogens regulate the cell cycle in cultured breast cancer cells, in particular, in MCF-7 cells. Here, we discuss how estrogens exert control over several key G1 phase cell-cycle regulators, namely cyclin D1, Myc, Cdk2, Cdk4, Cdk inhibitors and Cdc25A. Although the molecular mechanisms underlying estrogenic regulation of G1 phase regulators are far from clear, current evidence indicates that estrogens might regulate several key molecules required for S phase entry, this regulation being independent of cell-cycle transit per se.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11504672     DOI: 10.1016/s1043-2760(01)00436-2

Source DB:  PubMed          Journal:  Trends Endocrinol Metab        ISSN: 1043-2760            Impact factor:   12.015


  58 in total

1.  Quantitative measurement of cell migration using time-lapse videomicroscopy and non-linear system analysis.

Authors:  Nikolaus Wick; Stefan Thurner; Karin Paiha; Roland Sedivy; Ilja Vietor; Lukas A Huber
Journal:  Histochem Cell Biol       Date:  2003-01-08       Impact factor: 4.304

2.  Ginkgetin induces cell death in breast cancer cells via downregulation of the estrogen receptor.

Authors:  Yoonhwa Park; Sang Hyeok Woo; Sung-Keum Seo; Hyunggee Kim; Woo Chul Noh; Jin Kyung Lee; Byoung-Mog Kwon; Kyung Nam Min; Tae-Boo Choe; In-Chul Park
Journal:  Oncol Lett       Date:  2017-08-10       Impact factor: 2.967

3.  Estrogen regulation of cyclin E2 requires cyclin D1 but not c-Myc.

Authors:  C Elizabeth Caldon; C Marcelo Sergio; Judith Schütte; Marijke N Boersma; Robert L Sutherland; Jason S Carroll; Elizabeth A Musgrove
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

4.  Estrogen regulates JNK1 genomic localization to control gene expression and cell growth in breast cancer cells.

Authors:  Miao Sun; Gary D Isaacs; Nasun Hah; Nina Heldring; Elizabeth A Fogarty; W Lee Kraus
Journal:  Mol Endocrinol       Date:  2012-03-22

5.  Survival signals generated by estrogen and phospholipase D in MCF-7 breast cancer cells are dependent on Myc.

Authors:  Vanessa Rodrik; Yang Zheng; Faith Harrow; Yuhong Chen; David A Foster
Journal:  Mol Cell Biol       Date:  2005-09       Impact factor: 4.272

Review 6.  Pathways to tamoxifen resistance.

Authors:  Rebecca B Riggins; Randy S Schrecengost; Michael S Guerrero; Amy H Bouton
Journal:  Cancer Lett       Date:  2007-05-01       Impact factor: 8.679

7.  Estrogen regulation of TRPM8 expression in breast cancer cells.

Authors:  Dechen Chodon; Arnaud Guilbert; Isabelle Dhennin-Duthille; Mathieu Gautier; Marie-Sophie Telliez; Henri Sevestre; Halima Ouadid-Ahidouch
Journal:  BMC Cancer       Date:  2010-05-19       Impact factor: 4.430

8.  Estrogen receptor beta-selective agonists stimulate calcium oscillations in human and mouse embryonic stem cell-derived neurons.

Authors:  Lili Zhang; Brigitte E Blackman; Marcus D Schonemann; Tatjana Zogovic-Kapsalis; Xiaoyu Pan; Mary Tagliaferri; Heather A Harris; Isaac Cohen; Renee A Reijo Pera; Synthia H Mellon; Richard I Weiner; Dale C Leitman
Journal:  PLoS One       Date:  2010-07-27       Impact factor: 3.240

9.  Extracellular signal-regulated kinase 7, a regulator of hormone-dependent estrogen receptor destruction.

Authors:  Lorin M Henrich; Jeffrey A Smith; Danielle Kitt; Timothy M Errington; Binh Nguyen; Abdulmaged M Traish; Deborah A Lannigan
Journal:  Mol Cell Biol       Date:  2003-09       Impact factor: 4.272

10.  Hes-6, an inhibitor of Hes-1, is regulated by 17beta-estradiol and promotes breast cancer cell proliferation.

Authors:  Johan Hartman; Eric W-F Lam; Jan-Ake Gustafsson; Anders Ström
Journal:  Breast Cancer Res       Date:  2009-11-05       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.